Please Wait
Applying Filters...
menu
    • menu
    CDMO Activity Tracker: Lupin’s CDMO commissions oncology block in India; Cambrex, Axplora, Hovione expand operations

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    Tiklid

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 73Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    30/12/2025 Siegfried AG
    Switzerland
    		 Siegfried Evionnaz SA 219MF10303 Ticlopidine hydrochloride 2007-09-28 2018-11-14 Route du Simplon 1,36,CH-1902 Evionnaz,Switzerland
    30/12/2025 Liaoyuan Pharmaceutical
    China
    		 Zhejiang Liaoyuan Pharmaceutical Co. , Ltd. 219MF10251 JP Ticlopidine Hydrochloride (for manufacturing purpose... 2007-07-26 2019-03-15 Zhejiang Provincial Chemical and Medical Raw Material Base Linhai Zone Duqiao town, Linhai City, Zhejiang Province, China
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.